Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery
By improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center successfully reduced inpatient opioid use by 50% after pancreatic cancer surgery and cut the median opioid prescription volumes at discharge to zero. This approach, described in a study published today in JAMA Surgery, could help reduce the risk of long-term … Read more